V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009537 | 260006141 | 1.56 | 0 | Curative (C) | null | 2014-03-28 | Rituximab | Y | N | 260030085 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 260009538 | 260006141 | null | 65 | null | 2013-04-28 | 2013-04-28 | Bendamustine +/- Prednisolone | N | N | 260030085 | CISPLATIN + ETOPOSIDE |
| 260009539 | 260006141 | 1.68 | 55.5 | Curative (C) | 2014-09-19 | 2014-09-19 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260030085 | CARBOPLATIN + PEMETREXED |
| 260009540 | 260006141 | 1.67 | 85.2 | Neo-adjuvant (N) | 2013-06-07 | 2013-06-14 | Cisplatin + Etoposide (5 day) | 02 | null | 260030085 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009541 | 260006142 | 1.67 | 84.9 | Palliative (P) | 2016-10-16 | 2016-10-27 | CVP R + GEMCITABINE | 01 | N | 260030093 | CARBOPLATIN + VINORELBINE |
| 260009542 | 260006143 | 1.63 | 72.2 | Palliative (P) | 2015-04-24 | 2015-04-28 | Rituximab | N | N | 260030095 | RITUXIMAB |
| 260009543 | 260012290 | 1.74 | null | Palliative (P) | 2016-02-14 | 2016-02-15 | CISPLATIN + ETOPOSIDE | 02 | N | 260030097 | GALLIUM TRIAL |
| 260009544 | 260006144 | 1.76 | null | Curative (C) | 2013-07-27 | 2013-07-30 | Cisplatin + Etoposide (3 day) | N | N | 260030098 | CISPLATIN + ETOPOSIDE |
| 260009545 | 260006144 | 1.75 | 79 | Curative (C) | 2016-07-06 | 2016-07-13 | Gemcitabine + Oxaliplatin | 1 | null | 260030098 | ETOPOSIDE |
| 260009546 | 260006145 | 1.85 | 73 | null | 2014-02-24 | 2014-03-06 | Cisplatin + Etoposide (3 day) | 02 | N | 260030109 | CISPLATIN + ETOPOSIDE |
| 260009547 | 260006145 | 0 | 72 | Curative (C) | 2017-10-23 | 2017-10-24 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260030109 | CHLORAMBUCIL + RITUXIMAB |
| 260009548 | 260006145 | null | 79.6 | Curative (C) | 2013-03-06 | 2013-04-02 | Bendamustine + prednisolone | N | Y | 260030109 | CISPLATIN |
| 260009549 | 260006145 | null | 0 | Curative (C) | null | 2014-02-22 | CISPLATIN + VINORELBINE | null | null | 260030109 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260009550 | 260006146 | 1.73 | null | Palliative (P) | 2014-10-27 | 2014-10-27 | Carboplatin + Etoposide IV 3 day | Y | N | 260030115 | ETOPOSIDE |
| 260009551 | 260006147 | 1.77 | 69.7 | Palliative (P) | 2014-07-29 | 2014-07-29 | EP | N | N | 260030116 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009552 | 260006147 | 1.56 | 72 | Disease modification (D) | null | 2015-04-07 | FEC 60 or 75 | N | N | 260030116 | CARBOPLATIN + PACLITAXEL |
| 260009553 | 260015666 | 1.82 | 0 | Adjuvant (A) | 2014-04-14 | 2014-04-14 | GC Int Guide Excranial GermCell JEB | 02 | Y | 260030118 | GEMCITABINE + OXALIPLATIN |
| 260009554 | 260006148 | 1.82 | 81.8 | Not known (9) | 2017-08-10 | 2017-08-25 | Cisplatin + Etoposide (5 day) | 01 | null | 260030119 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260009555 | 260006148 | 1.71 | 91.4 | Disease modification (D) | 2015-07-15 | 2015-07-28 | BOP | N | N | 260030119 | CARBOPLATIN + PEMETREXED |
| 260009556 | 260006149 | null | 0 | Curative (C) | 2013-12-02 | 2013-12-05 | Chlorambucil | 99 | null | 260030125 | RITUXIMAB |
| 260009557 | 260006149 | 1.8 | 101 | Palliative (P) | 2017-10-20 | 2017-10-22 | EP | 2 | N | 260030125 | TIP |
| 260009558 | 260006150 | 1.68 | 66.9 | Disease modification (D) | 2015-09-04 | 2015-09-05 | Carboplatin 21day + Paclitaxel 7day | N | N | 260030127 | CARBOPLATIN + PACLITAXEL |
| 260009559 | 260006150 | null | 74 | Palliative (P) | 2016-09-30 | 2016-10-18 | Carboplatin + Etoposide IV 3 day | N | N | 260030127 | RITUXIMAB |
| 260009560 | 260006151 | 1.61 | 75.5 | Curative (C) | 2013-07-22 | 2013-08-18 | CARBOPLATIN + PACLITAXEL | N | N | 260030133 | FCR |
| 260009561 | 260012297 | null | 84 | Curative (C) | null | 2019-03-30 | Cisplatin + Etoposide (5 day) | N | N | 260030137 | CARBOPLATIN + ETOPOSIDE |
| 260009566 | 260006153 | 1.61 | 65.5 | Curative (C) | 2013-08-12 | 2013-08-20 | R Chlorambucil | 02 | N | 260030144 | CHOP |
| 260009567 | 260006153 | 1.71 | null | Palliative (P) | 2015-08-31 | 2015-09-10 | CVP R + GEMCITABINE | N | N | 260030144 | CISPLATIN + VINORELBINE |
| 260009568 | 260006153 | null | 104.2 | Curative (C) | 2013-02-12 | 2013-02-13 | 111 Trial (formerly BEP 111) | null | Y | 260030144 | CARBOPLATIN + ETOPOSIDE |
| 260009569 | 260006154 | 1.8 | 87.4 | Curative (C) | 2016-03-04 | 2016-03-08 | 111 Trial (formerly BEP 111) | N | N | 260030153 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE |
| 260009570 | 260006155 | null | 91.4 | Adjuvant (A) | null | 2017-05-18 | ICE + GCSF | N | N | 260030159 | CISPLATIN + ETOPOSIDE |
| 260009571 | 260012300 | 1.75 | 60.5 | Curative (C) | 2015-09-04 | 2015-09-10 | ETOPOSIDE + RITUXIMAB | 2 | N | 260000643 | RITUXIMAB |
| 260009572 | 260006156 | 1.82 | 71.2 | Disease modification (D) | 2017-02-08 | 2017-02-13 | CISPLATIN + ETOPOSIDE | 02 | N | 260000841 | CISPLATIN + ETOPOSIDE |
| 260009573 | 260006156 | 1.66 | 97.6 | Curative (C) | 2017-02-14 | 2017-02-16 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 01 | N | 260000841 | ETOPOSIDE |
| 260009574 | 260006157 | 1.79 | 97.5 | Disease modification (D) | 2013-11-01 | 2014-12-20 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260002431 | CISPLATIN + ETOPOSIDE |
| 260009575 | 260006157 | 1.54 | null | Curative (C) | 2013-11-09 | 2013-11-12 | CHOP - 21 days | 02 | N | 260002431 | CISPLATIN |
| 260009576 | 260006158 | 1.6 | 88.6 | Disease modification (D) | 2018-02-11 | 2018-02-17 | Rituximab | 2 | Y | 260005189 | CARBOPLATIN + PACLITAXEL |
| 260009577 | 260012303 | null | null | Palliative (P) | 2017-01-18 | 2017-10-08 | Cisplatin + Etoposide (3 day) | N | N | 260005418 | CISPLATIN + ETOPOSIDE |
| 260009578 | 260006159 | 1.79 | 107.4 | Curative (C) | 2014-08-04 | 2016-02-13 | Cisplatin + Etoposide (5 day) | 02 | N | 260005444 | ETOPOSIDE |
| 260009579 | 260006159 | null | 89 | null | null | 2013-10-16 | Cisplatin + Etoposide (3 day) | null | null | 260005444 | CISPLATIN + ETOPOSIDE |
| 260009580 | 260006160 | 1.8 | 81 | Adjuvant (A) | 2017-02-24 | 2017-03-08 | Cisplatin + Etoposide (3 day) | N | N | 260005534 | ETOPOSIDE |
| 260009581 | 260006160 | 1.55 | 0 | Curative (C) | null | 2017-01-25 | Rituximab (Maintenance) | N | N | 260005534 | RITUXIMAB |
| 260009582 | 260006161 | 1.88 | 76.7 | null | 2014-10-30 | 2014-11-15 | Cisplatin + Etoposide (3 day) | 02 | N | 260005619 | IVA |
| 260009583 | 260006161 | 1.77 | 72 | null | null | 2019-01-17 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | null | null | 260005619 | CARBOPLATIN + ETOPOSIDE |
| 260009584 | 260006161 | null | 0 | Curative (C) | null | 2016-12-24 | Rituximab | 02 | null | 260005619 | HYDROXYCARBAMIDE |
| 260009585 | 260006162 | null | 74.5 | Not known (9) | 2018-02-26 | 2018-02-28 | CISPLATIN + ETOPOSIDE | N | null | 260005805 | CISPLATIN + ETOPOSIDE |
| 260009586 | 260006162 | 1.65 | 86.5 | Curative (C) | 2017-08-02 | 2017-08-27 | Carboplatin + Paclitaxel (3 weekly) | 1 | N | 260005805 | RITUXIMAB |
| 260009587 | 260006162 | 1.73 | 99.6 | null | 2017-07-08 | 2017-08-17 | Cisplatin + Etoposide (5 day) | 1 | null | 260005805 | NOT MATCHED |
| 260009588 | 260006163 | 1.69 | 69.2 | Disease modification (D) | 2017-04-03 | 2017-04-03 | Rituximab | N | N | 260005873 | RITUXIMAB |
| 260009589 | 260012308 | 1.82 | null | Disease modification (D) | 2017-12-13 | 2017-12-15 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260005973 | CISPLATIN + ETOPOSIDE |
| 260009590 | 260006164 | 1.74 | 47.9 | Disease modification (D) | 2018-10-18 | 2018-11-02 | Cisplatin + Etoposide (3 day) | 02 | N | 260005976 | CARBOPLATIN + PACLITAXEL |